Primary aldosteronism, a condition characterized by excessive aldosterone production from the adrenal glands, accounts for 5–15% of all hypertension cases globally yet remains significantly underdiagnosed in routine clinical practice. A comprehensive Nature Reviews Disease Primers review by Vaidya and colleagues highlights the critical gap between disease prevalence and detection rates across different healthcare systems.
The review emphasizes that systematic screening protocols—particularly in patients with resistant hypertension and specific clinical phenotypes—can substantially improve early identification and enable targeted, personalized treatment strategies. Accurate diagnosis is essential because management approaches differ markedly: unilateral disease may be amenable to surgical intervention, while bilateral disease typically requires long-term medical therapy with mineralocorticoid antagonists.
By implementing evidence-based screening strategies and improving clinical awareness, clinicians can reduce misdiagnosis, prevent cardiovascular complications, and optimize patient outcomes. Read the full article on GMJ Newsroom.
Was this article helpful?
